Skip navigation
Browsing by Author Frost, N.
Showing results 1 to 1 of 1
| Preview | Issue Date | Title / Name | Author(s) |
| May-2024 | Four-year outcomes and circulating tumor DNA (ctDNA) analysis of pembrolizumab (pembro) plus concurrent chemoradiation therapy (cCRT) in unresectable, locally advanced, stage III non–small-cell lung cancer (NSCLC): From KEYNOTE-799. | Reck, M.; Lee, K. H.; Frost, N.; Breder, V. V.; Kowalski, D. M.; Levchenko, E.; Reguart, N.; Martinez-Marti, A.; Houghton, B.; Paoli, J. B.; Safina, S.; Liu, H.; Novinskiy, V.; Dettman, E. J.; Kobie, J.; Jabbour, S. K.; Houghton, Baerin | |
